logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8859814 B1

PDFFull Text
Date of Patent:
Oct. 14, 2014

Filed:

May. 14, 2009

[object object]

Applicants:

Derek Cogan, Sandy Hook, CT (US);

Alexander Heim-riether, Newtown, CT (US);

Wang Mao, Milford, CT (US);

Craig Andrew Miller, Norwalk, CT (US);

Philip Dean Ramsden, Woodbury, CT (US);

Lana Louise Smith Keenan, Poughquag, NY (US);

Roger John Snow, Danbury, CT (US);

Jiang-ping Wu, Danbury, CT (US);

Yu Yang, Clark, NJ (US);

Inventors:

Derek Cogan, Sandy Hook, CT (US);

Alexander Heim-Riether, Newtown, CT (US);

Wang Mao, Milford, CT (US);

Craig Andrew Miller, Norwalk, CT (US);

Philip Dean Ramsden, Woodbury, CT (US);

Lana Louise Smith Keenan, Poughquag, NY (US);

Roger John Snow, Danbury, CT (US);

Jiang-Ping Wu, Danbury, CT (US);

Yu Yang, Clark, NJ (US);

Assignee:

Boehringer Ingelheim International GmbH, Ingelheim am Rhein, DE;

Attorneys:

Michael P. Morris

Edward S. Lazer

Primary Examiner:

Kendra D Carter

Int. Cl.
CPC ...
C07C 303/00 (2006.01); C07C 307/00 (2006.01); C07C 309/00 (2006.01); C07C 311/00 (2006.01); C07C 241/00 (2006.01); C07C 241/02 (2006.01); C07D 211/00 (2006.01); C07D 211/68 (2006.01); C07D 211/80 (2006.01); C07D 213/02 (2006.01); C07D 217/00 (2006.01); C07D 209/04 (2006.01); C07D 231/00 (2006.01); C07D 277/60 (2006.01); C07D 277/62 (2006.01); C07D 211/22 (2006.01); C07D 403/12 (2006.01); C07D 217/06 (2006.01); C07D 295/185 (2006.01); C07D 513/04 (2006.01); C07D 487/04 (2006.01); C07D 211/70 (2006.01); C07D 401/14 (2006.01); C07D 209/08 (2006.01); C07D 211/62 (2006.01); C07C 311/19 (2006.01); C07D 211/16 (2006.01); C07D 409/12 (2006.01); C07D 413/12 (2006.01); C07C 311/44 (2006.01); C07D 407/12 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07C 311/19 (2013.01); C07D 211/22 (2013.01); C07D 403/12 (2013.01); C07D 217/06 (2013.01); C07D 295/185 (2013.01); C07D 513/04 (2013.01); C07D 487/04 (2013.01); C07D 211/70 (2013.01); C07D 401/14 (2013.01); C07D 209/08 (2013.01); C07D 211/62 (2013.01); C07D 211/16 (2013.01); C07D 409/12 (2013.01); C07D 413/12 (2013.01); C07C 311/44 (2013.01); C07D 407/12 (2013.01); C07D 401/12 (2013.01);
Abstract

Disclosed is a compound of formula (I). Wherein R, RAr and Cy are as defined herein, or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions of the compound of formula (I), methods of making the compounds of formula I, and methods of using the compounds of formula (I) to treat a disorder associated with activation of CCR10.

Find Patent Forward Citations

Loading…